Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
Location status: Recruiting
Location contact
Charlotte Abeshaus
CONTACT
Lauren Hammer, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06848530
The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement disorders. This study attempts to better understand the brain electrical activity associated with these disorders, both in patients with and without deep brain stimulation (DBS). Recordings are made from the scalp with a noninvasive electrode and/or through the DBS stimulator if the participant has a stimulator model that is able to sense brain activity. These recordings are analyzed along with measures of movement disorder symptoms to identify brain signal signatures of symptoms.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19107, United States
Location status: Recruiting
Charlotte Abeshaus
CONTACT
Lauren Hammer, MD, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
participant's movement disorders medications, prescribed by their treating physician
Deep brain stimulator parameters may be adjusted within normal clinical limits
Time frame: 5 years
Spatiotemporal patterns of brain neural activity (neural signal biomarkers / neurophysiologic signatures) associated with movement disorders symptoms.
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06553625
Basal Ganglia Diseases, Brain Diseases
Cologne, Germany
View Trial DetailsNCT00001208
Central Nervous System Diseases, Movement Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT06821230
Basal Ganglia Diseases, Brain Diseases
Hong Kong
View Trial DetailsNCT05822388
Basal Ganglia Diseases, Brain Diseases
Charleston, South Carolina, United States
View Trial Details